Celyad Oncology

Celyad Oncology is a company listed under the stock ticker CYAD (BE).

View the org chart displaying its 14 main executives

Georges Rawadi, Chief Executive Officer, has left the company (posted on December 5 2023).
Michel Lussier, who was Non-Executive Director, is promoted to Interim Chief Executive Officer and Director (posted on December 5 2023).

Create your alert
to follow the executive moves at Celyad Oncology.

Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
Histogen has filed for bankruptcy protection (posted on April 19 2024).

Contact by email its executives including Michel Lussier Premium

The best decision-maker directory

Discover the organization charts of your favorite companies.

Spot the influential executives using our search tools.

Receive notifications when executive positions change.

Fuel your company's success with our real-time data.

Individual Access

Executive Data Sets

Executives

Companies

The Official Board